Page-3 of COVAXIN
India approved two COVID-19 vaccines for Emergency Use
The Drug Controller General of India recently announced that it has authorised two COVID-19 vaccines for restricted Emergency Use in India. What are the two COVID-19 Vaccines approved by DGCI for emergency use? COVAXIN and COVISHIELD What is COVAXIN? The ..
Month: Current Affairs - January, 2021
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by ..
Month: Current Affairs - January, 2021
COVAXIN of Bharat Biotech enters Phase III trials: Largest COVID-19 clinical trial of India
On November 16, 2020 the Bharat Biotech announced the commencement of Phase III trials of COVAXIN vaccines in India. The trials will involve 26,000 volunteers. It is to be held in partnership with the Indian Council of Medical Research. The ..
Month: Current Affairs - November, 2020
Mission COVID Suraksha: Key Facts
On November 12, 2020, the Finance Minister Nirmala Sitharaman announced Mission COVID Suraksha. Under the mission, the Government of India has allocated Rs 900 crores to the research and development of COVID-19 vaccines in India. The funds allocated do not ..
Month: Current Affairs - November, 2020
India-Bangladesh sign MoU on COVID-19 Vaccine
On November 5, 2020, the Government of Bangladesh signed a Memorandum of Understanding with the Serum Institute of India for priority delivery of 3 crore COVID-19 vaccine doses. This COVISHIELD Vaccines was developed by AstraZeneca and University of Oxford. Highlights ..
Month: Current Affairs - November, 2020
EpicVacCorona: Second COVID-19 Vaccine approved by Russia
The Russian Authorities have approved a new COVID-19 vaccine called “EpicVacCorona”. It is a two shot vaccine. Key Highlights EpiVacCorona is a peptide-based vaccine. Sputnik V was the first vaccine developed by Russia. Russia is to conduct the vaccine trial ..
Month: Current Affairs - October, 2020
COVAXIN to use Alhydroxiquim-II to boost Immune Response
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has sought the approval of Drugs Controller General of India to begin phase ..
Month: Current Affairs - October, 2020
COVID-19 Vaccine: Serum Institute of India to produce additional 100 million doses for India
The Serum Institute of India recently announced that it will produce additional 100 million COVID-19 vaccines for low- and middle- income countries by 2021. Highlights Earlier, the institute had committed to deliver 100 million vaccines. Now a total of 200 ..
Month: Current Affairs - September, 2020
ICMR to allow COVID-19 vaccines with 50% efficacy
The Indian Council for Medical Research approves COVID-19 vaccines with 50-100% efficacy. According to ICMR, no respiratory vaccines have 100% efficacy. Highlights According to the World Health Organization, a vaccine should have three things namely safety, efficacy and immunogenicity. Immunogenicity ..
Month: Current Affairs - September, 2020
What Immunization Programme Mechanism will GoI use to distribute COVID-19 vaccines?
The Government of India is to use the Universal Immunization Programme mechanism to distribute covid-19 vaccines in the country. This was announced by the Union Health Minister Harsh Vardhan during his address in the Lok Sabha. Universal Immunization Programme Under ..